<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<HTML><HEAD><TITLE>Molecular Cloning | Protocol 9 Print Version</TITLE>
<META http-equiv=Content-Type content="text/html; charset=windows-1251"><!--================== Designed and Developed by WriteDesign =================--><!--======================= Powered by RomeBlack, Inc. =======================--><!--=== Copyright 2000, 2001 Cold Spring Harbor Labs. All Rights Reserved. ===-->
<META content="" name=keywords>
<META 
content="This stage of the procedure describes the transfection with target genes of cell lines already expressing inducible tTA. In this example, the target genes are transfected on a plasmid that carries puromycin resistance as a selectable marker." 
name=description>
<META content="MSHTML 5.50.4134.600" name=GENERATOR></HEAD>
<BODY bgColor=#ffffff background=../izo/fon.gif>
<table width=600 border="0" cellspacing="0" cellpadding="0"><tr><td width=600><IMG height=49 hspace=4 src="../izo/logo_csh.gif" 
width=169 align=left vspace=4><IMG height=49 hspace=4 
src="../izo/print_header.gif" width=293 align=left vspace=4><BR 
clear=all><BR><FONT face="arial,verdana, helvetica" size=4><STRONG>Chapter 17, 
Protocol 9</STRONG></FONT><BR><BR clear=all><FONT face=arial,verdana,helvetica 
size=3><STRONG>Tetracycline as Regulator of Inducible Gene Expression<BR>Stage 
2: Stable Transfection of Inducible tTA-expressing NIH-3T3 Cells with 
Tetracycline-regulated Target Genes</STRONG></FONT><BR><BR><FONT 
face="arial,verdana, helvetica" size=2>This stage of the procedure describes the 
transfection with target genes of cell lines already expressing inducible tTA. 
In this example, the target genes are transfected on a plasmid that carries 
puromycin resistance as a selectable marker.</FONT> <BR><BR>
<TABLE border=1>
  <TBODY>
  <TR>
    <TD width=700><IMG height=11 alt=CSH hspace=4 src="../izo/triangle.gif" 
      width=11 border=0><FONT face=arial,verdana,helvetica 
      size=2><STRONG>CAUTION</STRONG></FONT><BR><IMG height=12 alt="" hspace=4 
      src="../izo/circle.gif" width=12 border=0><FONT 
      face="arial,verdana, helvetica" size=2> <STRONG>RECIPE</STRONG></FONT> 
  </TD></TR></TBODY></TABLE><BR><BR><FONT face=arial,verdana,helvetica 
size=3><STRONG>MATERIALS</STRONG></FONT><BR><BR>
<TABLE cellPadding=0 cellborder="0">
  <TBODY>
  <TR>
    <TD vAlign=top align=left><FONT face="arial,verdana, helvetica" 
      size=2><STRONG>Buffers and Solutions</STRONG></FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>Calf serum 
      (10%)</FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>HEPES-buffered 
      saline</FONT> <IMG height=12 alt="" hspace=4 src="../izo/circle.gif" 
      width=12 border=0> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>PBS</FONT> 
      <IMG height=12 alt="" hspace=4 src="../izo/circle.gif" width=12 
      border=0> </TD></TR>
  <TR>
    <TD><IMG height=10 src="../izo/spacer.gif" width=1 border=0></TD></TR>
  <TR>
    <TD vAlign=top align=left><FONT face="arial,verdana, helvetica" 
      size=2><STRONG>Enzymes and Buffers</STRONG></FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>Appropriate 
      restriction endonuclease(s)</FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>1x 
      Trypsin-EDTA</FONT> <IMG height=12 alt="" hspace=4 
      src="../izo/circle.gif" width=12 border=0> </TD></TR>
  <TR>
    <TD><IMG height=10 src="../izo/spacer.gif" width=1 border=0></TD></TR>
  <TR>
    <TD vAlign=top align=left><FONT face="arial,verdana, helvetica" 
      size=2><STRONG>Media</STRONG></FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>DMEM selection 
      medium containing 500 µM L-histidinol and 0.5 µg/ml tetracycline (with or 
      without 3 µg/ml puromycin)</FONT> <IMG height=12 alt="" hspace=4 
      src="../izo/circle.gif" width=12 border=0> </TD></TR>
  <TR>
    <TD><IMG height=10 src="../izo/spacer.gif" width=1 border=0></TD></TR>
  <TR>
    <TD vAlign=top align=left><FONT face="arial,verdana, helvetica" 
      size=2><STRONG>Additional Reagents</STRONG></FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>Step 3 of this 
      stage requires the reagents listed in <A href="../17/08.htm">Chapter 
      17, Protocol 8</A>.</FONT> </TD></TR>
  <TR>
    <TD><IMG height=10 src="../izo/spacer.gif" width=1 border=0></TD></TR>
  <TR>
    <TD vAlign=top align=left><FONT face="arial,verdana, helvetica" 
      size=2><STRONG>Vectors and Bacterial Strains</STRONG></FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>pPGKPuro (or 
      vector carrying another selectable marker)</FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2><I>Purify all 
      plasmids by equilibrium centrifugation in CsCl-ethidium bromide gradients 
      (<A href="../01/10.htm">Chapter 
      1, Protocol 10</A>) or by column chromatography (<A href="../01/09.htm">Chapter 
      1, Protocol 9</A>).</I><I>The plasmids pTet-Splice and pUHC13-3 are 
      available from Life Technologies. Other vectors carrying selectable 
      markers are commercially available (e.g., pCI-neo from Promega and pTK-HYG 
      or pPUR from CLONTECH). If another vector is substituted for pPGKPuro, 
      then use the appropriate selection media for the selectable marker carried 
      by that plasmid.</I></FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>pTet-Splice 
      carrying a reporter gene (optional, e.g., pUHC13-3)</FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>pTet-Splice 
      carrying the target gene ORF(s)</FONT> </TD></TR>
  <TR>
    <TD><IMG height=10 src="../izo/spacer.gif" width=1 border=0></TD></TR>
  <TR>
    <TD vAlign=top align=left><FONT face="arial,verdana, helvetica" 
      size=2><STRONG>Cells and Tisssues</STRONG></FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>Stable cell 
      lines that inducibly express autoregulatory tTA (<A href="08.htm">Chapter 
      17, Protocol 8</A>)</FONT> </TD></TR>
  <TR>
    <TD><IMG height=10 src="../izo/spacer.gif" width=1 
  border=0></TD></TR></TBODY></TABLE><BR><BR><FONT 
face="arial,verdana,&#13;&#10;    helvetica" 
size=3><STRONG>METHOD</STRONG></FONT> <BR><FONT face="arial,verdana, helvetica" 
color=#000000 size=2>
<OL>
  <LI><FONT face="arial,verdana, helvetica" color=#000000 size=2>Culture stable 
  cell lines that inducibly express autoregulatory tTA (isolated in <A href="08.htm">Chapter 
  17, Protocol 8</A>) in complete selection medium containing 500 µm 
  L-histidinol and 0.5 µg/ml tetracycline-HCl. The day before transfection, 
  passage the cells into 10-cm tissue culture dishes containing complete 
  selection medium. Transfer enough cells per dish so that on the day of the 
  transfection, the cell monolayers will be 33% 
  confluent.<BR><B>IMPORTANT</B><I> From this point on, maintain the cells in 
  the presence of 0.5 µg/ml tetracycline-HCl at 37°C, in an atmosphere of 5% 
  CO<SUB>2</SUB> unless otherwise stated.</I> </FONT>
  <LI><FONT face="arial,verdana, helvetica" color=#000000 size=2>Linearize the 
  plasmids to be used for transfection and adjust the DNA concentration of each 
  to <IMG src="../izo/greaterthen.gif">0.5 mg/ml. Mix 10-20 µg of each target 
  gene plasmid(s) and 1-2 µg of pPGKPuro (a 10:1 molar ratio of each 
  tetracycline plasmid to selectable marker plasmid) with 500 µl of 
  HEPES-buffered saline in a clear 4-ml polystyrene tube.<BR><I>Prepare a 
  control for mock transfection containing HEPES-buffered saline and no DNA. All 
  of the mock-transfected cells should die when incubated in a medium containing 
  puromycin. Please see the note to Step 4.</I> </FONT>
  <LI><FONT face="arial,verdana, helvetica" color=#000000 size=2>Carry out Steps 
  3-13 from <A href="08.htm">Chapter 
  17, Protocol 8</A>.<BR><B>IMPORTANT</B><I> Be sure to substitute the selection 
  medium containing 500 µM L-histidinol and 0.5 µg/ml tetracycline-HCl in this 
  transfection, whenever Stage 1 calls for DMEM complete containing 
  tetracycline.</I> </FONT>
  <LI><FONT face="arial,verdana, helvetica" color=#000000 size=2>Forty-eight 
  hours after transfection, passage the cells into DMEM selection medium 
  containing 500 µM L-histidinol, 3 µg/ml puromycin, and 0.5 µg/ml tetracycline 
  at several dilutions ranging from approx. 1 x 10<SUP>6</SUP> to 3 x 
  10<SUP>4</SUP> cells per 10-cm plate. Include several plates containing 
  approx. 1 x 10<SUP>5</SUP> cells.<BR><I>The lowest concentration of puromycin 
  that kills all untransfected cells within a few days should be determined 
  empirically before transfection and varies with the cell type. A concentration 
  of 3 µg/ml puromycin is sufficient for selection of transfected NIH-3T3 cells. 
  Most types of cells are killed efficiently in concentrations of puromycin 
  ranging from 0.1 µg/ml to 10 µg/ml.</I> </FONT>
  <LI><FONT face="arial,verdana, helvetica" color=#000000 size=2>After 
  incubating cultures in DMEM selection medium for 4 days, feed them with a 
  further 3-4 ml of DMEM selection medium containing 500 µM L-histidinol, 3 
  µg/ml puromycin, and 0.5 µg/ml tetracycline. </FONT>
  <LI><FONT face="arial,verdana, helvetica" color=#000000 size=2>When colonies 
  are well-established (at day 12-14 of selection), delineate their borders by 
  drawing a circle on the bottom of the culture dish around each colony. 
  Aspirate the medium from the plate, and place a sterile plastic cloning ring 
  on the plate to surround an individual clone. Repeat the procedure with each 
  colony that is to be picked. Choose cells from plates on which individual 
  colonies are well spaced and can be easily distinguished. </FONT>
  <LI><FONT face="arial,verdana, helvetica" color=#000000 size=2>Quickly wash 
  the clones with approx. 100 µl of PBS. To release the cells, add 2 drops of 1x 
  trypsin-EDTA (approx. 100 µl) and incubate for 30-60 seconds. Loosen the cells 
  by pipetting up and down with a Pasteur pipette. Transfer each colony to one 
  well of a 24-well tissue culture plate that contains 1 ml of DMEM selection 
  medium containing 500 µm L-histidinol, 3 µg/ml puromycin, and 0.5 µg/ml 
  tetracycline.<BR><I>Carry out all subsequent passaging of cells by a standard 
  procedure, such as (i) a quick PBS wash, and (ii) a 1-3-minute incubation with 
  trypsin-EDTA (2 ml per confluent 10-cm plate) using 10% calf serum (3 ml) to 
  dilute/stop the activity of the trypsin.</I> </FONT>
  <LI><FONT face="arial,verdana, helvetica" color=#000000 size=2>When cells in 
  the wells have grown to 80% confluency, transfer them into 6-cm dishes that 
  contain DMEM selection medium containing 500 µM L-histidinol, 3 µg/ml 
  puromycin, and 0.5 µg/ml tetracycline.<BR><I>NIH-3T3 cells become 80% 
  confluent in approx. 4-7 days; however, the time required to reach 80% 
  confluency varies from cell line to cell line and even from clone to 
  clone.</I> </FONT>
  <LI><FONT face="arial,verdana, helvetica" color=#000000 size=2>Expand the 
  cells (typically use a 1:5 to 1:10 dilution of the cells) in DMEM selection 
  medium containing 500 µm L-histidinol, 3 µg/ml puromycin, and 0.5 µg/ml 
  tetracycline. </FONT>
  <LI><FONT face="arial,verdana, helvetica" color=#000000 size=2>When cell 
  monolayers are again approx. 80% confluent, recover a portion of each clone of 
  the cells and store them in aliquots in liquid nitrogen. Passage the remainder 
  of the cells until they have expanded sufficiently to allow testing for 
  inducible expression of the target gene product(s) as described in <A href="10.htm">Chapter 
  17, Protocol 10</A>.<BR><I>When the frozen cells are later used, they should 
  be revived and grown in selection medium containing 500 µm L-histidinol, 3 
  µg/ml puromycin, and 0.5 µg/ml tetracycline-HCl.</I> 
</FONT></LI></OL></FONT><BR><BR><FONT 
face="arial,verdana,&#13;&#10;    helvetica" size=3><STRONG>RECIPES</STRONG> 
</FONT><IMG height=11 alt=CSH hspace=4 src="../izo/circle.gif" width=12 
border=0> <BR><BR>
<TABLE border=0>
  <TBODY>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD vAlign=top align=left width=400><FONT face=arial,verdana,helvetica 
      color=#000000 size=2><STRONG>DMEM Selection medium containing 500 µM 
      L-histidinol and 3 µg/ml puromycin (with or without 0.5 µg/ml 
      tetracycline)</STRONG></FONT> </TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>histidine-free DMEM 
      </FONT></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>100 units/ml 
      penicillin</FONT></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>100 µg/ml streptomycin 
      </FONT></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>2 mM 
  glutamine</FONT></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>10% bovine calf serum 
      </FONT></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>125, 250, or 500 µM 
      l-histidinol (dilute in a 125 mM stock and store it at -20°C)</FONT></TD></TR>
  <TR>
    <TD><IMG height=12 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>
      <P>Histidine-free DMEM is available from Irvine Scientific (Santa Ana, 
      California).</P>
      <P>Add tetracycline to 0.5 µg/ml when appropriate (prepare a 10 mg/ml 
      stock of tetracycline-HCl in 70% ethanol and store at -20°C). Selection 
      medium that contains 0.5 µg/ml tetracycline-HCl may be stored protected 
      from the light for approx. 1 month at 4°C.</P>
      <P>Add puromycin to 3 µg/ml when 
appropriate.</P></FONT></TD></TR></TBODY></TABLE><BR>
<TABLE border=0>
  <TBODY>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD vAlign=top align=left width=400><FONT face=arial,verdana,helvetica 
      color=#000000 size=2><STRONG>EDTA</STRONG></FONT> </TD></TR>
  <TR>
    <TD><IMG height=12 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>To prepare EDTA at 0.5 M 
      (pH 8.0): Add 186.1 g of disodium EDTA•2H<SUB>2</SUB>O to 800 ml of 
      H<SUB>2</SUB>O. Stir vigorously on a magnetic stirrer. Adjust the pH to 
      8.0 with NaOH (approx. 20 g of NaOH pellets). Dispense into aliquots and 
      sterilize by autoclaving. The disodium salt of EDTA will not go into 
      solution until the pH of the solution is adjusted to approx. 8.0 by the 
      addition of NaOH.</FONT></TD></TR></TBODY></TABLE><BR>
<TABLE border=0>
  <TBODY>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD vAlign=top align=left width=400><FONT face=arial,verdana,helvetica 
      color=#000000 size=2><STRONG>HEPES-buffered saline</STRONG></FONT> </TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>140 mM NaCl</FONT></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>1.5 mM 
      Na<SUB>2</SUB>HPO<SUB>4</SUB>•2H<SUB>2</SUB>O</FONT></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>50 mM HEPES</FONT></TD></TR>
  <TR>
    <TD><IMG height=12 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>For a 2x solution: 
      Dissolve 0.8 g of NaCl, 0.027 g of 
      Na<SUB>2</SUB>HPO<SUB>4</SUB>•2H<SUB>2</SUB>O, and 1.2 g of HEPES in a 
      total volume of 90 ml of distilled H<SUB>2</SUB>O. Adjust the pH to 7.05 
      with 0.5 n NaOH , and then adjust the volume to 100 ml with distilled 
      H<SUB>2</SUB>O. Sterilize the solution by passing it through a 0.22-µm 
      filter; store the filtrate in 5-ml aliquots at -20°C for periods of up to 
      1 year. </FONT></TD></TR></TBODY></TABLE><BR>
<TABLE border=0>
  <TBODY>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD vAlign=top align=left width=400><FONT face=arial,verdana,helvetica 
      color=#000000 size=2><STRONG>KCl</STRONG></FONT> </TD></TR>
  <TR>
    <TD><IMG height=12 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>Dissolve an appropriate 
      amount of solid KCl in H<SUB>2</SUB>O, autoclave for 20 minutes on liquid 
      cycle and store at room temperature. Ideally, this 4 M solution should be 
      divided into small (approx. 100 µl) aliquots in sterile tubes and each 
      aliquot thereafter used one time.</FONT></TD></TR></TBODY></TABLE><BR>
<TABLE border=0>
  <TBODY>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD vAlign=top align=left width=400><FONT face=arial,verdana,helvetica 
      color=#000000 size=2><STRONG>NaCl</STRONG></FONT> </TD></TR>
  <TR>
    <TD><IMG height=12 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>To prepare a 5 M 
      solution: Dissolve 292 g of NaCl in 800 ml of H<SUB>2</SUB>O. Adjust the 
      volume to 1 liter with H<SUB>2</SUB>O. Dispense into aliquots and 
      sterilize by autoclaving. Store the NaCl solution at room 
      temperature.</FONT></TD></TR></TBODY></TABLE><BR>
<TABLE border=0>
  <TBODY>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD vAlign=top align=left width=400><FONT face=arial,verdana,helvetica 
      color=#000000 size=2><STRONG>PBS</STRONG></FONT> </TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>137 mM NaCl</FONT></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>2.7 mM KCl</FONT></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>10 mM 
      Na<SUB>2</SUB>HPO<SUB>4</SUB></FONT></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>2 mM 
      KH<SUB>2</SUB>PO<SUB>4</SUB></FONT></TD></TR>
  <TR>
    <TD><IMG height=12 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>(Phosphate-buffered 
      Saline) Dissolve 8 g of NaCl, 0.2 g of KCl, 1.44 g of 
      Na<SUB>2</SUB>HPO<SUB>4</SUB>, and 0.24 g of KH<SUB>2</SUB>PO<SUB>4</SUB> 
      in 800 ml of distilled H<SUB>2</SUB>O. Adjust the pH to 7.4 with HCl. Add 
      H<SUB>2</SUB>O to 1 liter. Dispense the solution into aliquots and 
      sterilize them by autoclaving for 20 minutes at 15 psi (1.05 kg/cm 
      <SUP>2</SUP>) on liquid cycle or by filter sterilization. Store the buffer 
      at room temperature. If necessary, PBS may be supplemented with 1 mM 
      CaCl<SUB>2</SUB> and 0.5 mM 
MgCl<SUB>2</SUB>.</FONT></TD></TR></TBODY></TABLE><BR>
<TABLE border=0>
  <TBODY>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD vAlign=top align=left width=400><FONT face=arial,verdana,helvetica 
      color=#000000 size=2><STRONG>Trypsin</STRONG></FONT> </TD></TR>
  <TR>
    <TD><IMG height=12 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>Prepare bovine trypsin at 
      a concentration of 250 µg/ml in 200 mM ammonium bicarbonate (pH 8.9) 
      (Sequencer grade; Boehringer Mannheim). Store the solution in aliquots at 
      -20°C.</FONT></TD></TR></TBODY></TABLE><BR>
<TABLE border=0>
  <TBODY>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD vAlign=top align=left width=400><FONT face=arial,verdana,helvetica 
      color=#000000 size=2><STRONG>Trypsin-EDTA</STRONG></FONT> </TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>0.05% 
trypsin</FONT></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>0.5 mM EDTA (pH 
      8.0)</FONT></TD></TR></TBODY></TABLE><BR><BR><BR><BR><BR>
<OL></OL><BR><BR><BR><BR><BR><FONT face=Arial,Verdana,Helvetica 
size=1><STRONG>Copyright © 2000 by Cold Spring Harbor Laboratory Press. All 
rights reserved.</STRONG><BR>No part of these pages, either text or image may be 
used for any purpose other than personal use. Therefore, reproduction 
modification, storage in a retrieval system or retransmission, in any form or by 
any means, electronic, mechanical, or otherwise, for reasons other than personal 
use, is strictly prohibited without prior written 
permission.</FONT><BR><BR>
</td></tr></table>
</BODY></HTML>
